Free Publication in 2018
Free Publication in 2018
Osamu Yokosuka is an Emeritus Professor of Chiba University, Japan. He graduated from Chiba University School of Medicine in 1975 then worked as a trainee under Professor K. Okuda in Chiba University Hospital till 1978. Dr. Yokosuka was a research fellow worked under Professor S. Scherlock and Professor B. H. Billing in Royal Free Hospital, London, UK from 1978 to 1980; under Professor M. Omata in Chiba University from 1980 to 1985; and under Dr. J Summers in Fox Chase Cancer Center, PA, USA in 1984. In 1985, he received a Degree of Doctor of Medical Science, and served as an Assistant Professor in Chiba University till 1994, then as Lecturer in Medicine till 2006 when he was appointed as Director and Professor of Medicine. From 2013 to 2015, he served as the Dean of Chiba University School of Medicine.
Dr. Yokosuka was the Secretary General of APASL (2008-2014). In 2016, he was elected as the President of APASL Tokyo, the President of 52nd Annual Meeting of Japan Society of Hepatology, and the President of Funabashi Central Hospital. Dr. Yokosuka’s research mainly focuses on Hepatitis and Hepatocellular Carcinoma. So far, he has published more than 700 original papers.
Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure-track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. In 2017, Tatsuo Kanda became an Associate Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nihon University School of Medicine. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journal.
Epigenetic Mechanisms in Health and Disease
Submission Deadline: May 31, 2018 (Open) Submit Now
Stéphane Viville, PhD
Marcel Mannens, PhD
Title: Epigenetic changes if in vitro fertilization and embryo culture in humans
Title: Epigenetic regulation by androgen receptor in prostate cancer
Title: Epigenetics and Human Reproduction
Title: Update on Epigenetics Landscape in Parkinson Disease and Lewy Body Dementia
Title: non-coding RNAs in Melanoma development, progression and dissemination
Title: Similarities and differences of epigenetic mechanisms in chronic lymphocytic leukemia, myelodysplasia and acute myelod leukemia
Title: Uniparental disomy and imprinting disorders
Title: Deciphering the epigenetic landscape of suicidal behaviour: a review of current findings, caveats and future directions
Title: Functionnal Screening for DNA methylation inhibition, HDAC and sirtuin inhibition and Histone methylation (also functionnal assay) and differenciation of myeloma cells (functionnal also).
Title: Epigenetics in the actions of melatonin
Title: Epigenetics of migraine
Title: Runs of homozygosity/long contiguous stretches of homozygosity (ROH/LCSH) and epigenetic deregulation of genomic imprinting
Title: Histone O-GlcNAcylation and its potential role
Title: Nucleolar stress involvement in generation of autoantigens in autoimmune diseases
Title: Epigenetics of IgA nephropathy: a brief review
Title: Epigenetics and infectious disease, state of the art and prespectives in new generation therapies